![Turnstone Biologics Corporation](/common/images/company/N_TSBX.png)
Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across mu... Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient's tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0504 | -10.8644104333 | 0.4639 | 0.4733 | 0.365 | 357052 | 0.41062179 | CS |
4 | -0.0356 | -7.92696504119 | 0.4491 | 0.5319 | 0.365 | 365537 | 0.44767711 | CS |
12 | -0.0545 | -11.6452991453 | 0.468 | 0.6232 | 0.365 | 206206 | 0.4754859 | CS |
26 | -1.8465 | -81.703539823 | 2.26 | 2.2614 | 0.365 | 316898 | 0.63328134 | CS |
52 | -1.7865 | -81.2045454545 | 2.2 | 5.75 | 0.365 | 226764 | 1.33961503 | CS |
156 | -10.9865 | -96.3728070175 | 11.4 | 13.2 | 0.365 | 180592 | 1.96815745 | CS |
260 | -10.9865 | -96.3728070175 | 11.4 | 13.2 | 0.365 | 180592 | 1.96815745 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約